Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Muzamil Yaqub Want, Anna Konstorum, Ruea-Yea Huang, Vaibhav Jain, Satoko Matsueda, Takemasa Tsuji, Amit Lugade, Kunle Odunsi, Richard Koya & Sebastiano Battaglia. (2019) Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancer. OncoImmunology 8:6.
Read now
Read now
Shiro Suzuki, Jun Sakata, Fumi Utsumi, Ryuichiro Sekiya, Hiroaki Kajiyama, Kiyosumi Shibata, Fumitaka Kikkawa & Tetsuya Nakatsura. (2016) Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma. OncoImmunology 5:11.
Read now
Read now
Yu Sawada, Toshiaki Yoshikawa, Kazuya Ofuji, Mayuko Yoshimura, Nobuhiro Tsuchiya, Mari Takahashi, Daisuke Nobuoka, Naoto Gotohda, Shinichiro Takahashi, Yuichiro Kato, Masaru Konishi, Taira Kinoshita, Masafumi Ikeda, Kohei Nakachi, Naoya Yamazaki, Shoichi Mizuno, Tadatoshi Takayama, Kenji Yamao, Katsuhiko Uesaka, Junji Furuse, Itaru Endo & Tetsuya Nakatsura. (2016) Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients. OncoImmunology 5:5.
Read now
Read now
Jonathan Pol, Norma Bloy, Aitziber Buqué, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Peptide-based anticancer vaccines. OncoImmunology 4:4.
Read now
Read now
Articles from other publishers (21)
Xiaoxiao Jin, Xiaotao Liu, Zining Zhou, Yan Ding, Yandan Wu, Jie Qiu & Chuanlai Shen. (2021) Identification of HLA-A2 restricted epitopes of glypican-3 and induction of CTL responses in HLA-A2 transgenic mice. Cancer Immunology, Immunotherapy 71:7, pages 1569-1582.
Crossref
Crossref
Dmytro S. Voropaiev, Iryna A. Brizhata, Oleksandr S. Stepanenko & Nataliia V. Petrenko. (2022) Particularities of Multidisciplinary Approach in Physical Therapy. Acta Balneologica 64:1, pages 77-82.
Crossref
Crossref
Mayu Ukai, Akira Yokoi, Kosuke Yoshida, Shiro Suzuki, Kiyosumi Shibata, Fumitaka Kikkawa, Tetsuya Nakatsura & Hiroaki Kajiyama. (2021) Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma. Cancers 13:3, pages 550.
Crossref
Crossref
Emmanuelle Benard, Nicholas P. Casey, Else Marit Inderberg & Sébastien Wälchli. (2020) SJI 2020 special issue: A catalogue of Ovarian Cancer targets for CAR therapy. Scandinavian Journal of Immunology 92:4.
Crossref
Crossref
Zhiquan Liang, Ziwen Lu, Yafei Zhang, Dongsheng Shang, Ruyan Li, Lanlan Liu, Zhicong Zhao, Peishan Zhang, Qiong Lin, Chunlai Feng, Yibang Zhang, Peng Liu, Zhigang Tu & Hanqing Liu. (2019) Targeting Membrane Receptors of Ovarian Cancer Cells for Therapy. Current Cancer Drug Targets 19:6, pages 449-467.
Crossref
Crossref
Yu Akazawa, Daisuke Nobuoka, Mari Takahashi, Toshiaki Yoshikawa, Manami Shimomura, Shoichi Mizuno, Toshiyoshi Fujiwara, Yasunari Nakamoto & Tetsuya Nakatsura. (2019) Higher human lymphocyte antigen class I expression in early‐stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes. Cancer Science 110:6, pages 1842-1852.
Crossref
Crossref
Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, Itaru Endo & Tetsuya Nakatsura. (2019) Next-Generation Cancer Immunotherapy Targeting Glypican-3. Frontiers in Oncology 9.
Crossref
Crossref
Shuzhen Liu, Wen Liu, Danrui Zhao, Yan Zhang, Zhenzhen Zhao & Bing Luo. (2019) The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China. Oncology Research and Treatment 42:11, pages 572-579.
Crossref
Crossref
Sylvie Ricard-Blum & Sylvain D. Vallet. (2019) Fragments generated upon extracellular matrix remodeling: Biological regulators and potential drugs. Matrix Biology 75-76, pages 170-189.
Crossref
Crossref
Sjoerd H. van der Burg. (2018) Correlates of immune and clinical activity of novel cancer vaccines. Seminars in Immunology 39, pages 119-136.
Crossref
Crossref
Dragana Nikitovic, Aikaterini Berdiaki, Ioanna Spyridaki, Theodoros Krasanakis, Aristidis Tsatsakis & George N. Tzanakakis. (2018) Proteoglycans—Biomarkers and Targets in Cancer Therapy. Frontiers in Endocrinology 9.
Crossref
Crossref
Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo & Tetsuya Nakatsura. (2018) Cancer immunotherapy-targeted glypican-3 or neoantigens. Cancer Science 109:3, pages 531-541.
Crossref
Crossref
Danrui Zhao, Shuzhen Liu, Lingling Sun, Zhenzhen Zhao, Song Liu, Xiaojing Kuang, Jun Shu & Bing Luo. (2016) Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma. Virus Research 220, pages 52-56.
Crossref
Crossref
Norihiro Fujinami, Toshiaki Yoshikawa, Yu Sawada, Manami Shimomura, Tatsuaki Iwama, Shiori Sugai, Shigehisa Kitano, Yasushi Uemura & Tetsuya Nakatsura. (2016) Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model. Biochemistry and Biophysics Reports 5, pages 482-491.
Crossref
Crossref
Tetsuya NAKATSURA. (2016) Era of cancer immunotherapy has come. Japanese Journal of Clinical Immunology 39:3, pages 164-171.
Crossref
Crossref
Dong-hui Wang, Xiao-hua Wu, Su-min Qian & Hai-Rong Yao. (2015) Study on the mesothelin-specific cytotoxicity against epithelial ovarian cancer with full-length mesothelin cDNA-transduced dendritic cells. Medical Oncology 32:4.
Crossref
Crossref
Justin M. Drerup, Yang Liu, Alvaro S. Padron, Kruthi Murthy, Vincent Hurez, Bin Zhang & Tyler J. Curiel. (2015) Immunotherapy for Ovarian Cancer. Current Treatment Options in Oncology 16:1.
Crossref
Crossref
Maria Tretiakova, Debra L. Zynger, Chunyan Luan, Nicole K. Andeen, Laura S. Finn, Masha Kocherginsky, Bin T. Teh & Ximing J. Yang. (2014) Glypican 3 overexpression in primary and metastatic Wilms tumors. Virchows Archiv 466:1, pages 67-76.
Crossref
Crossref
Toshiaki Yoshikawa, Yu Sawada, Mayuko Yoshimura, Kazuya Ofuji & Tetsuya Nakatsura. 2015. Inflammation and Immunity in Cancer. Inflammation and Immunity in Cancer
133
143
.
Tasuku Mariya, Yoshihiko Hirohashi, Toshihiko Torigoe, Takuya Asano, Takafumi Kuroda, Kazuyo Yasuda, Masahito Mizuuchi, Tomoko Sonoda, Tsuyoshi Saito & Noriyuki Sato. (2014) Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer. Cancer Immunology Research 2:12, pages 1220-1229.
Crossref
Crossref
CHENHONG LUO, KIYOSUMI SHIBATA, SHIRO SUZUKI, HIROAKI KAJIYAMA, TAKESHI SENGA, YOSHIHIRO KOYA, MINA DAIMON, MAMORU YAMASHITA & FUMITAKA KIKKAWA. (2014) GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth. Oncology Reports 32:3, pages 913-921.
Crossref
Crossref